Strides board approves USD 15 mn investment in Stelis Biopharma
New Delhi: Strides Pharma Science Thursday said its board has approved plans to invest another USD 15 million in its biotech arm Stelis Biopharma. The company’s board has approved participation…
Monsanto appeals damning Roundup cancer verdict
San Francisco: Monsanto on Tuesday said it is asking an appeals court to toss out a damning verdict in a landmark Roundup weed-killer cancer trial and grant it another try.…
Piramal Enterprises plans to raise up to Rs 1,000 crore via NCDs
NEW DELHI: Piramal Enterprises Wednesday said it plans to raise up to Rs 1,000 crore through issue of secured non-convertible debentures (NCDs) on private placement basis. The administrative committee of…
Piramal Pharma Solutions announces completion of new lab facility
MUMBAI: Piramal Pharma Solutions (PPS), a contract development and manufacturing organization, announced the completion of its new cGMP kilo lab suite at its API (Active Pharmaceutical Ingredient) site in Ennore…
U.S. appeals court declines J&J bid to stop generic Zytiga sales
By Jan Wolfe A U.S. appeals court on Wednesday declined a request by Johnson & Johnson for a temporary restraining order blocking sales of generic versions of its blockbuster prostate…
Roche-AbbVie cancer drug gets accelerated FDA approval
Roche Holding AG said on Wednesday its cancer drug, Venclexta, received accelerated approval from the U.S. Food and Drug Administration as part of a combination treatment for newly diagnosed patients…
Only a handful of pharma cos are developing the much needed medicines for the poor : ATMI 2018
Amsterdam, the Netherlands, 20 November 2018 – The development of new medical products that are considered the highest priority for people in developing countries is highly concentrated – among five…
Novo Nordisk Education Foundation launches ‘1000-Day Challenge’ to impact diabetes care
New Delhi, 13 November 2018. To mark World Diabetes Day, Novo Nordisk Education Foundation (NNEF) and Novo Nordisk India Pvt Ltd have launched a ‘1000-day Challenge’ programme along with leading…
AstraZeneca Pharma India Q2 net profit dips 67% to Rs 9.13 cr
New Delhi: Drug firm AstraZeneca Pharma India Tuesday reported a 66.65 per cent dip in its net profit to Rs 9.13 crore for the quarter ended September 30, 2018. The…
Antibiotic resistance kills over 50,000 children in India annually
Antibiotic-resistant infections are spreading wings in India, killing over 58,000 children every year, while uncontrolled dumping of untreated urban waste into water bodies is affecting aquatic life and environment. With…
